Unibest

Pharmaceutical intermediates

Ropivacaine Hydrochloride Hydrate Intermediates

2 pharmaceutical intermediates for Ropivacaine Hydrochloride Hydrate. Indication: Anesthesia.

提交项目All intermediates

About Ropivacaine Hydrochloride Hydrate

Originator
Astrazeneca
Indication
Anesthesia
Approved Date
09/24/1996

Available intermediates

2 intermediates currently listed for Ropivacaine Hydrochloride Hydrate. Request specifications, documentation or a quotation for any item below.

Ropivacaine Hydrochloride Hydrate intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide15883-20-2//
(2S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide27262-40-4//

Other programs under R

Ramelteon RegorafenibRelugolixRemdesivir RemibrutinibRepotrectinibResmetiromRevumenib

Building toward Ropivacaine Hydrochloride Hydrate?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →